Open AccessS178: SAFETY AND EFFICACY OF BELANTAMAB MAFODOTIN IN COMBINATION WITH RD IN NEWLY DIAGNOSED, TRANSPLANT INELIGIBLE MULTIPLE MYELOMA PATIENTS: A PHASE 1/2 STUDY BY THE HELLENIC SOCIETY OF HEMATOLOGY
Author(s) -
Terpos E.,
Gavriatopoulou M.,
NtanasisStathopoulos I.,
Malandrakis P.,
Fotiou D.,
Kanellias N.,
Gkolfinopoulos S.,
Manousou K.,
Kastritis E.,
Dimopoulos M.A.
Publication year - 2022
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/01.hs9.0000843604.69106.e8
Subject(s) - medicine , lenalidomide , tolerability , pomalidomide , multiple myeloma , regimen , oncology , cohort , adverse effect , surgery